according to the American Cancer Society. GSK’s acquisition of IDRx will include IDRX-42 which is currently being developed and trialled as therapy for the treatment of gastrointestinal stomal ...

GSK isn't revealing the size of the OS improvement yet – it has promised to do so at the American Society for Haematology ... At this year's ASCO cancer congress in February, earlier results ...

OWN, through its health initiative OWN Your Health, has partnered with the American Cancer Society's VOICES of Black Women campaign.

The American Cancer Society is betting on generative AI’s potential to accelerate cancer research, having struck a multi-year collaboration with Layer Health this month. Boston-based Layer ...

The results were featured at the American Society of Haematology (ASH) annual meeting and, according to GSK, "support the potential ... treatment for the blood cancer. After being all but written ...

The Swiss pharma giant – which has its U.S. headquarters in East Hanover – said it aims to encourage football fans to "proactively manage their health." ...